Drug profile · INN
milsaperidone
BYSANTI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
milsaperidone (BYSANTI) is an FDA-listed pharmaceutical active ingredient. Associated with Vanda Pharmaceuticals Netherlands B.V.. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN milsaperidone
Brand BYSANTI
Route ORAL
Formulation TABLET
Originator Vanda Pharmaceuticals Netherlands B.V.
Frequently asked questions
What is milsaperidone?
milsaperidone (BYSANTI) is an FDA-listed pharmaceutical active ingredient. Associated with Vanda Pharmaceuticals Netherlands B.V.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for milsaperidone?
BYSANTI is a marketed brand name for milsaperidone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of milsaperidone?
milsaperidone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.